Martin Shkreli

Convicted securities fraudster and former hedge fund manager infamous for raising Daraprim's price from $13.50 to $750 per pill, exploiting immunocompromised patients. Served ~5 years in prison and was released in 2022. Now active in fintech and crypto, building Gödel Terminal and frequently posting on biotech, markets, and trading. Widely recognized as exceptionally intelligent on finance, probability, and drug development, but reputation remains heavily damaged by the Daraprim scandal, fraud conviction, and repeated involvement in crypto pump-and-dump schemes. Presence characterized by provocative, unfiltered commentary that generates both sharp market insights and persistent distrust—described variously as brilliant yet toxic, knowledgeable yet manipulative, and impossible to separate from a legacy of greed and ethical violations.